Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO2884 | Annona squamosa | Species | Annonaceae | Eukaryota | TCMID* | |||
NPO5919 | Phoebe cinnamomifolia | Species | Lauraceae | Eukaryota | TCMID* | |||
NPO11053 | Annona purpurea | Species | Annonaceae | Eukaryota | TCMID* | |||
NPO15739 | Annona mucosa | Species | Annonaceae | Eukaryota | TCMID* | |||
NPO25761 | Thalictrum microgynum | Species | Ranunculaceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT2 | Others | Unspecified | Activity | = | 91.2 | % | 9868142 | |
NPT2 | Others | Unspecified | Activity | = | 43.7 | % | 9868142 | |
NPT2 | Others | Unspecified | Activity | = | 53.5 | % | 9868142 | |
NPT2 | Others | Unspecified | Activity | = | 87.2 | % | 9868142 | |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 11220.2 | nM | PubChem BioAssay data set |
NPT1197 | Individual Protein | Huntingtin | Homo sapiens | Potency | = | 11220.2 | nM | PubChem BioAssay data set |
NPT1038 | Individual Protein | Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 11220.2 | nM | PubChem BioAssay data set |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 35481.3 | nM | PubChem BioAssay data set |
NPT4033 | Individual Protein | Protein Rev | Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1) | IC50 | > | 75418 | nM | PubChem BioAssay data set |
NPT791 | Individual Protein | Cruzipain | Trypanosoma cruzi | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT795 | Individual Protein | Zinc finger protein mex-5 | Caenorhabditis elegans | EC50 | = | 4831 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | EC50 | > | 110000 | nM | PubChem BioAssay data set | |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 19905.4 | nM | PubChem BioAssay data set |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 19952.6 | nM | PubChem BioAssay data set |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT524 | Individual Protein | Serine-protein kinase ATM | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT797 | Individual Protein | Cytoplasmic zinc-finger protein | Caenorhabditis elegans | EC50 | = | 28614 | nM | PubChem BioAssay data set |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 16360.1 | nM | PubChem BioAssay data set | ||
NPT4034 | Individual Protein | Putative hexokinase HKDC1 | Homo sapiens | IC50 | = | 12100 | nM | PubChem BioAssay data set |
NPT4035 | Individual Protein | Female germline-specific tumor suppressor gld-1 | Caenorhabditis elegans | IC50 | = | 6152 | nM | PubChem BioAssay data set |
NPT4034 | Individual Protein | Putative hexokinase HKDC1 | Homo sapiens | IC50 | = | 10100 | nM | PubChem BioAssay data set |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 70794.6 | nM | PubChem BioAssay data set | |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 6513.1 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 13115.4 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 14125.4 | nM | PubChem BioAssay data set | |
NPT1397 | Cell Line | INS1 | Rattus norvegicus | AC50 | = | 3344 | nM | PubChem BioAssay data set |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 10000 | nM | PubChem BioAssay data set | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1000 | nM | PubChem BioAssay data set | ||
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 18526 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 18356.4 | nM | PubChem BioAssay data set | ||
NPT71 | Cell Line | HEK293 | Homo sapiens | Potency | 259.3 | nM | PubChem BioAssay data set | |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 3264.3 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 8199.5 | nM | PubChem BioAssay data set | |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 3548.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 3662.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 4109.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3548.1 | nM | PubChem BioAssay data set | ||
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | 4466.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1995.3 | nM | PubChem BioAssay data set | ||
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 3548.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 12589.3 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC90875 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9808 | High Similarity | NPC233334 |
0.9712 | High Similarity | NPC24019 |
0.9626 | High Similarity | NPC207283 |
0.9626 | High Similarity | NPC84164 |
0.9581 | High Similarity | NPC15406 |
0.9537 | High Similarity | NPC124313 |
0.9423 | High Similarity | NPC210434 |
0.9349 | High Similarity | NPC182907 |
0.9349 | High Similarity | NPC189903 |
0.9321 | High Similarity | NPC77878 |
0.9321 | High Similarity | NPC183537 |
0.9302 | High Similarity | NPC108342 |
0.9209 | High Similarity | NPC22481 |
0.9128 | High Similarity | NPC166722 |
0.9087 | High Similarity | NPC146976 |
0.907 | High Similarity | NPC278525 |
0.9045 | High Similarity | NPC210296 |
0.9038 | High Similarity | NPC236668 |
0.8959 | High Similarity | NPC119134 |
0.8626 | High Similarity | NPC470020 |
0.8618 | High Similarity | NPC122463 |
0.8559 | High Similarity | NPC270515 |
0.8326 | Intermediate Similarity | NPC322482 |
0.8203 | Intermediate Similarity | NPC251160 |
0.817 | Intermediate Similarity | NPC470018 |
0.8133 | Intermediate Similarity | NPC132385 |
0.8133 | Intermediate Similarity | NPC74575 |
0.8125 | Intermediate Similarity | NPC133140 |
0.8125 | Intermediate Similarity | NPC195268 |
0.8108 | Intermediate Similarity | NPC174049 |
0.8079 | Intermediate Similarity | NPC253675 |
0.807 | Intermediate Similarity | NPC49547 |
0.8051 | Intermediate Similarity | NPC134637 |
0.8018 | Intermediate Similarity | NPC473822 |
0.7992 | Intermediate Similarity | NPC478045 |
0.7965 | Intermediate Similarity | NPC470017 |
0.7963 | Intermediate Similarity | NPC16452 |
0.7963 | Intermediate Similarity | NPC36229 |
0.7963 | Intermediate Similarity | NPC476581 |
0.7956 | Intermediate Similarity | NPC216612 |
0.7946 | Intermediate Similarity | NPC54066 |
0.7941 | Intermediate Similarity | NPC137353 |
0.7931 | Intermediate Similarity | NPC470022 |
0.7924 | Intermediate Similarity | NPC107123 |
0.7897 | Intermediate Similarity | NPC4071 |
0.7897 | Intermediate Similarity | NPC476582 |
0.7897 | Intermediate Similarity | NPC476578 |
0.7884 | Intermediate Similarity | NPC318068 |
0.7879 | Intermediate Similarity | NPC255800 |
0.7879 | Intermediate Similarity | NPC96584 |
0.787 | Intermediate Similarity | NPC201508 |
0.7866 | Intermediate Similarity | NPC302807 |
0.7824 | Intermediate Similarity | NPC31930 |
0.7819 | Intermediate Similarity | NPC129897 |
0.7806 | Intermediate Similarity | NPC208522 |
0.7803 | Intermediate Similarity | NPC235076 |
0.7787 | Intermediate Similarity | NPC191489 |
0.7783 | Intermediate Similarity | NPC188420 |
0.7783 | Intermediate Similarity | NPC246381 |
0.7778 | Intermediate Similarity | NPC100079 |
0.7778 | Intermediate Similarity | NPC23614 |
0.7758 | Intermediate Similarity | NPC149471 |
0.7758 | Intermediate Similarity | NPC271215 |
0.7721 | Intermediate Similarity | NPC224928 |
0.7713 | Intermediate Similarity | NPC53069 |
0.7713 | Intermediate Similarity | NPC202605 |
0.7713 | Intermediate Similarity | NPC112206 |
0.7713 | Intermediate Similarity | NPC296482 |
0.7713 | Intermediate Similarity | NPC202768 |
0.7709 | Intermediate Similarity | NPC469439 |
0.7703 | Intermediate Similarity | NPC290689 |
0.7696 | Intermediate Similarity | NPC477019 |
0.7668 | Intermediate Similarity | NPC220337 |
0.7665 | Intermediate Similarity | NPC46451 |
0.7661 | Intermediate Similarity | NPC88923 |
0.7661 | Intermediate Similarity | NPC315634 |
0.7661 | Intermediate Similarity | NPC100734 |
0.7647 | Intermediate Similarity | NPC308943 |
0.7647 | Intermediate Similarity | NPC193238 |
0.7647 | Intermediate Similarity | NPC313189 |
0.7647 | Intermediate Similarity | NPC72905 |
0.7615 | Intermediate Similarity | NPC142385 |
0.7615 | Intermediate Similarity | NPC234197 |
0.7604 | Intermediate Similarity | NPC127085 |
0.7565 | Intermediate Similarity | NPC118121 |
0.7563 | Intermediate Similarity | NPC41501 |
0.7556 | Intermediate Similarity | NPC171409 |
0.7556 | Intermediate Similarity | NPC96405 |
0.7544 | Intermediate Similarity | NPC204446 |
0.7532 | Intermediate Similarity | NPC94842 |
0.7532 | Intermediate Similarity | NPC471004 |
0.7531 | Intermediate Similarity | NPC217554 |
0.751 | Intermediate Similarity | NPC284141 |
0.749 | Intermediate Similarity | NPC470042 |
0.7489 | Intermediate Similarity | NPC135549 |
0.7489 | Intermediate Similarity | NPC222561 |
0.7477 | Intermediate Similarity | NPC137929 |
0.7477 | Intermediate Similarity | NPC164374 |
0.746 | Intermediate Similarity | NPC284685 |
0.7448 | Intermediate Similarity | NPC11408 |
0.7415 | Intermediate Similarity | NPC476999 |
0.7414 | Intermediate Similarity | NPC477788 |
0.7412 | Intermediate Similarity | NPC55470 |
0.7402 | Intermediate Similarity | NPC473639 |
0.74 | Intermediate Similarity | NPC282346 |
0.74 | Intermediate Similarity | NPC215837 |
0.7379 | Intermediate Similarity | NPC13603 |
0.7373 | Intermediate Similarity | NPC469792 |
0.7373 | Intermediate Similarity | NPC114335 |
0.7373 | Intermediate Similarity | NPC141915 |
0.7373 | Intermediate Similarity | NPC280964 |
0.7368 | Intermediate Similarity | NPC232225 |
0.736 | Intermediate Similarity | NPC473833 |
0.7344 | Intermediate Similarity | NPC253482 |
0.7339 | Intermediate Similarity | NPC85879 |
0.7339 | Intermediate Similarity | NPC326930 |
0.7339 | Intermediate Similarity | NPC475301 |
0.7339 | Intermediate Similarity | NPC53255 |
0.7331 | Intermediate Similarity | NPC476997 |
0.7325 | Intermediate Similarity | NPC475648 |
0.7321 | Intermediate Similarity | NPC210256 |
0.7319 | Intermediate Similarity | NPC200888 |
0.7319 | Intermediate Similarity | NPC473506 |
0.7306 | Intermediate Similarity | NPC1608 |
0.7306 | Intermediate Similarity | NPC146724 |
0.7302 | Intermediate Similarity | NPC328928 |
0.73 | Intermediate Similarity | NPC476996 |
0.73 | Intermediate Similarity | NPC476998 |
0.7288 | Intermediate Similarity | NPC122968 |
0.7288 | Intermediate Similarity | NPC475631 |
0.7288 | Intermediate Similarity | NPC328186 |
0.7288 | Intermediate Similarity | NPC475600 |
0.7288 | Intermediate Similarity | NPC477787 |
0.7288 | Intermediate Similarity | NPC87152 |
0.7288 | Intermediate Similarity | NPC228377 |
0.7288 | Intermediate Similarity | NPC476110 |
0.7277 | Intermediate Similarity | NPC473449 |
0.7269 | Intermediate Similarity | NPC217176 |
0.7269 | Intermediate Similarity | NPC475303 |
0.7269 | Intermediate Similarity | NPC316841 |
0.7269 | Intermediate Similarity | NPC292416 |
0.7269 | Intermediate Similarity | NPC475596 |
0.7269 | Intermediate Similarity | NPC473689 |
0.7261 | Intermediate Similarity | NPC472061 |
0.7261 | Intermediate Similarity | NPC4421 |
0.7261 | Intermediate Similarity | NPC298449 |
0.7257 | Intermediate Similarity | NPC470486 |
0.7257 | Intermediate Similarity | NPC471190 |
0.7257 | Intermediate Similarity | NPC471977 |
0.7257 | Intermediate Similarity | NPC476994 |
0.7257 | Intermediate Similarity | NPC475644 |
0.725 | Intermediate Similarity | NPC475406 |
0.7243 | Intermediate Similarity | NPC148889 |
0.7241 | Intermediate Similarity | NPC158020 |
0.7241 | Intermediate Similarity | NPC473089 |
0.7241 | Intermediate Similarity | NPC75600 |
0.7241 | Intermediate Similarity | NPC6576 |
0.7241 | Intermediate Similarity | NPC212768 |
0.7241 | Intermediate Similarity | NPC473115 |
0.724 | Intermediate Similarity | NPC472589 |
0.7238 | Intermediate Similarity | NPC319880 |
0.7238 | Intermediate Similarity | NPC320324 |
0.7238 | Intermediate Similarity | NPC30456 |
0.7238 | Intermediate Similarity | NPC244839 |
0.7234 | Intermediate Similarity | NPC122436 |
0.7233 | Intermediate Similarity | NPC471978 |
0.7231 | Intermediate Similarity | NPC101350 |
0.7222 | Intermediate Similarity | NPC477903 |
0.7222 | Intermediate Similarity | NPC89549 |
0.722 | Intermediate Similarity | NPC38959 |
0.722 | Intermediate Similarity | NPC327904 |
0.7218 | Intermediate Similarity | NPC67401 |
0.7216 | Intermediate Similarity | NPC471979 |
0.7208 | Intermediate Similarity | NPC237702 |
0.7205 | Intermediate Similarity | NPC208284 |
0.7204 | Intermediate Similarity | NPC312872 |
0.7196 | Intermediate Similarity | NPC190461 |
0.719 | Intermediate Similarity | NPC235685 |
0.719 | Intermediate Similarity | NPC476995 |
0.7184 | Intermediate Similarity | NPC188400 |
0.7178 | Intermediate Similarity | NPC35208 |
0.7178 | Intermediate Similarity | NPC327769 |
0.7177 | Intermediate Similarity | NPC203373 |
0.7166 | Intermediate Similarity | NPC475315 |
0.7166 | Intermediate Similarity | NPC324619 |
0.7161 | Intermediate Similarity | NPC76565 |
0.7161 | Intermediate Similarity | NPC250807 |
0.7161 | Intermediate Similarity | NPC57797 |
0.716 | Intermediate Similarity | NPC472588 |
0.7156 | Intermediate Similarity | NPC474009 |
0.7155 | Intermediate Similarity | NPC42678 |
0.7155 | Intermediate Similarity | NPC477909 |
0.7155 | Intermediate Similarity | NPC477907 |
0.7149 | Intermediate Similarity | NPC280799 |
0.7149 | Intermediate Similarity | NPC253314 |
0.7143 | Intermediate Similarity | NPC211920 |
0.7143 | Intermediate Similarity | NPC146824 |
0.7143 | Intermediate Similarity | NPC162530 |
0.7137 | Intermediate Similarity | NPC301368 |
0.7137 | Intermediate Similarity | NPC84815 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC90875 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8125 | Intermediate Similarity | NPD3922 | Approved |
0.8125 | Intermediate Similarity | NPD3921 | Approved |
0.8125 | Intermediate Similarity | NPD3924 | Approved |
0.8125 | Intermediate Similarity | NPD3923 | Approved |
0.8095 | Intermediate Similarity | NPD7886 | Phase 2 |
0.8095 | Intermediate Similarity | NPD7885 | Phase 2 |
0.8008 | Intermediate Similarity | NPD8350 | Clinical (unspecified phase) |
0.7824 | Intermediate Similarity | NPD6525 | Clinical (unspecified phase) |
0.7797 | Intermediate Similarity | NPD1483 | Discontinued |
0.7787 | Intermediate Similarity | NPD7708 | Approved |
0.7778 | Intermediate Similarity | NPD8091 | Phase 3 |
0.7713 | Intermediate Similarity | NPD3815 | Phase 1 |
0.7713 | Intermediate Similarity | NPD3816 | Phase 1 |
0.7665 | Intermediate Similarity | NPD3763 | Approved |
0.7661 | Intermediate Similarity | NPD7803 | Approved |
0.7654 | Intermediate Similarity | NPD4926 | Clinical (unspecified phase) |
0.7634 | Intermediate Similarity | NPD7069 | Discontinued |
0.7596 | Intermediate Similarity | NPD3920 | Phase 2 |
0.7531 | Intermediate Similarity | NPD6790 | Phase 1 |
0.75 | Intermediate Similarity | NPD6494 | Phase 2 |
0.746 | Intermediate Similarity | NPD7956 | Approved |
0.746 | Intermediate Similarity | NPD7955 | Approved |
0.7441 | Intermediate Similarity | NPD3386 | Phase 2 |
0.7386 | Intermediate Similarity | NPD7417 | Discontinued |
0.7373 | Intermediate Similarity | NPD5801 | Clinical (unspecified phase) |
0.7336 | Intermediate Similarity | NPD5488 | Discontinued |
0.7331 | Intermediate Similarity | NPD7862 | Clinical (unspecified phase) |
0.7328 | Intermediate Similarity | NPD6242 | Discontinued |
0.7322 | Intermediate Similarity | NPD6963 | Approved |
0.7322 | Intermediate Similarity | NPD6964 | Approved |
0.7316 | Intermediate Similarity | NPD6568 | Discontinued |
0.7316 | Intermediate Similarity | NPD7395 | Discontinued |
0.7269 | Intermediate Similarity | NPD6257 | Clinical (unspecified phase) |
0.7247 | Intermediate Similarity | NPD5482 | Discontinued |
0.7241 | Intermediate Similarity | NPD4429 | Discontinued |
0.7196 | Intermediate Similarity | NPD7414 | Clinical (unspecified phase) |
0.7176 | Intermediate Similarity | NPD4889 | Approved |
0.7174 | Intermediate Similarity | NPD5866 | Approved |
0.7156 | Intermediate Similarity | NPD6477 | Clinical (unspecified phase) |
0.7154 | Intermediate Similarity | NPD5483 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD7571 | Clinical (unspecified phase) |
0.7137 | Intermediate Similarity | NPD6741 | Clinical (unspecified phase) |
0.7137 | Intermediate Similarity | NPD5040 | Clinical (unspecified phase) |
0.713 | Intermediate Similarity | NPD7927 | Clinical (unspecified phase) |
0.7124 | Intermediate Similarity | NPD4989 | Phase 2 |
0.7124 | Intermediate Similarity | NPD3326 | Clinical (unspecified phase) |
0.7119 | Intermediate Similarity | NPD5805 | Approved |
0.7105 | Intermediate Similarity | NPD5429 | Discontinued |
0.7104 | Intermediate Similarity | NPD6361 | Phase 2 |
0.7095 | Intermediate Similarity | NPD4885 | Approved |
0.7087 | Intermediate Similarity | NPD4997 | Clinical (unspecified phase) |
0.7083 | Intermediate Similarity | NPD5022 | Discontinued |
0.7075 | Intermediate Similarity | NPD7169 | Suspended |
0.7064 | Intermediate Similarity | NPD4375 | Approved |
0.7061 | Intermediate Similarity | NPD3217 | Phase 2 |
0.7048 | Intermediate Similarity | NPD5513 | Phase 2 |
0.7046 | Intermediate Similarity | NPD2285 | Clinical (unspecified phase) |
0.7029 | Intermediate Similarity | NPD7426 | Phase 1 |
0.702 | Intermediate Similarity | NPD6531 | Approved |
0.702 | Intermediate Similarity | NPD6530 | Approved |
0.7016 | Intermediate Similarity | NPD6230 | Discontinued |
0.7016 | Intermediate Similarity | NPD7673 | Phase 3 |
0.7012 | Intermediate Similarity | NPD8052 | Clinical (unspecified phase) |
0.7012 | Intermediate Similarity | NPD4952 | Phase 3 |
0.7004 | Intermediate Similarity | NPD6716 | Phase 1 |
0.6996 | Remote Similarity | NPD6745 | Discontinued |
0.6992 | Remote Similarity | NPD2921 | Clinical (unspecified phase) |
0.6988 | Remote Similarity | NPD6460 | Clinical (unspecified phase) |
0.6972 | Remote Similarity | NPD7588 | Discontinued |
0.6971 | Remote Similarity | NPD7654 | Discontinued |
0.6963 | Remote Similarity | NPD1923 | Clinical (unspecified phase) |
0.6962 | Remote Similarity | NPD8479 | Phase 2 |
0.6958 | Remote Similarity | NPD3263 | Phase 3 |
0.6944 | Remote Similarity | NPD1620 | Clinical (unspecified phase) |
0.6943 | Remote Similarity | NPD3946 | Clinical (unspecified phase) |
0.694 | Remote Similarity | NPD5914 | Approved |
0.6936 | Remote Similarity | NPD8149 | Discontinued |
0.6926 | Remote Similarity | NPD4373 | Phase 2 |
0.6926 | Remote Similarity | NPD5658 | Approved |
0.6926 | Remote Similarity | NPD7467 | Discontinued |
0.6917 | Remote Similarity | NPD7859 | Phase 2 |
0.6916 | Remote Similarity | NPD6219 | Discontinued |
0.6913 | Remote Similarity | NPD7010 | Phase 3 |
0.6913 | Remote Similarity | NPD5530 | Phase 1 |
0.6911 | Remote Similarity | NPD5450 | Discontinued |
0.6906 | Remote Similarity | NPD6569 | Phase 2 |
0.6891 | Remote Similarity | NPD5930 | Phase 3 |
0.6888 | Remote Similarity | NPD5640 | Discontinued |
0.6887 | Remote Similarity | NPD6228 | Discontinued |
0.688 | Remote Similarity | NPD7225 | Discontinued |
0.6878 | Remote Similarity | NPD3354 | Phase 2 |
0.6877 | Remote Similarity | NPD6503 | Clinical (unspecified phase) |
0.6875 | Remote Similarity | NPD7278 | Phase 2 |
0.6875 | Remote Similarity | NPD7279 | Phase 2 |
0.687 | Remote Similarity | NPD4038 | Approved |
0.687 | Remote Similarity | NPD4037 | Approved |
0.687 | Remote Similarity | NPD4122 | Approved |
0.687 | Remote Similarity | NPD31 | Approved |
0.687 | Remote Similarity | NPD4039 | Approved |
0.687 | Remote Similarity | NPD4036 | Approved |
0.687 | Remote Similarity | NPD4035 | Approved |
0.687 | Remote Similarity | NPD4033 | Approved |
0.687 | Remote Similarity | NPD4034 | Approved |
0.687 | Remote Similarity | NPD32 | Approved |
0.687 | Remote Similarity | NPD3006 | Discontinued |
0.686 | Remote Similarity | NPD3259 | Approved |
0.6849 | Remote Similarity | NPD2899 | Discontinued |
0.6848 | Remote Similarity | NPD7690 | Clinical (unspecified phase) |
0.6846 | Remote Similarity | NPD3925 | Approved |
0.6844 | Remote Similarity | NPD4418 | Discontinued |
0.6815 | Remote Similarity | NPD6727 | Phase 2 |
0.68 | Remote Similarity | NPD4551 | Phase 2 |
0.6798 | Remote Similarity | NPD4558 | Phase 2 |
0.6792 | Remote Similarity | NPD4923 | Phase 1 |
0.6789 | Remote Similarity | NPD7558 | Phase 2 |
0.6787 | Remote Similarity | NPD8016 | Phase 3 |
0.6787 | Remote Similarity | NPD8017 | Clinical (unspecified phase) |
0.6786 | Remote Similarity | NPD2334 | Discontinued |
0.6778 | Remote Similarity | NPD6974 | Phase 3 |
0.6777 | Remote Similarity | NPD6247 | Clinical (unspecified phase) |
0.6776 | Remote Similarity | NPD6872 | Clinical (unspecified phase) |
0.6776 | Remote Similarity | NPD6962 | Phase 2 |
0.677 | Remote Similarity | NPD5975 | Clinical (unspecified phase) |
0.6769 | Remote Similarity | NPD4396 | Clinical (unspecified phase) |
0.6762 | Remote Similarity | NPD7710 | Clinical (unspecified phase) |
0.6751 | Remote Similarity | NPD7538 | Clinical (unspecified phase) |
0.675 | Remote Similarity | NPD7858 | Clinical (unspecified phase) |
0.675 | Remote Similarity | NPD5070 | Clinical (unspecified phase) |
0.6747 | Remote Similarity | NPD7729 | Clinical (unspecified phase) |
0.674 | Remote Similarity | NPD6550 | Discontinued |
0.6738 | Remote Similarity | NPD7222 | Phase 2 |
0.6736 | Remote Similarity | NPD5632 | Approved |
0.6734 | Remote Similarity | NPD5891 | Approved |
0.6733 | Remote Similarity | NPD4876 | Phase 3 |
0.6733 | Remote Similarity | NPD4875 | Phase 3 |
0.673 | Remote Similarity | NPD7925 | Phase 2 |
0.673 | Remote Similarity | NPD7924 | Phase 2 |
0.6724 | Remote Similarity | NPD4795 | Phase 2 |
0.6721 | Remote Similarity | NPD7268 | Clinical (unspecified phase) |
0.6721 | Remote Similarity | NPD7994 | Phase 2 |
0.6721 | Remote Similarity | NPD6553 | Clinical (unspecified phase) |
0.6713 | Remote Similarity | NPD1078 | Clinical (unspecified phase) |
0.6707 | Remote Similarity | NPD1505 | Phase 2 |
0.6703 | Remote Similarity | NPD8310 | Clinical (unspecified phase) |
0.6695 | Remote Similarity | NPD5601 | Phase 2 |
0.6695 | Remote Similarity | NPD4502 | Phase 2 |
0.6695 | Remote Similarity | NPD7703 | Clinical (unspecified phase) |
0.6694 | Remote Similarity | NPD7555 | Discontinued |
0.6694 | Remote Similarity | NPD6160 | Clinical (unspecified phase) |
0.6692 | Remote Similarity | NPD5867 | Clinical (unspecified phase) |
0.6682 | Remote Similarity | NPD2782 | Approved |
0.6682 | Remote Similarity | NPD2780 | Approved |
0.6681 | Remote Similarity | NPD3257 | Approved |
0.6681 | Remote Similarity | NPD5071 | Phase 2 |
0.668 | Remote Similarity | NPD6825 | Phase 1 |
0.668 | Remote Similarity | NPD7180 | Phase 3 |
0.6667 | Remote Similarity | NPD4724 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD5751 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD5512 | Phase 3 |
0.6667 | Remote Similarity | NPD6517 | Phase 3 |
0.6654 | Remote Similarity | NPD8100 | Phase 3 |
0.6654 | Remote Similarity | NPD7689 | Approved |
0.6653 | Remote Similarity | NPD5612 | Discontinued |
0.6653 | Remote Similarity | NPD2433 | Clinical (unspecified phase) |
0.6652 | Remote Similarity | NPD6138 | Clinical (unspecified phase) |
0.6652 | Remote Similarity | NPD1304 | Clinical (unspecified phase) |
0.6652 | Remote Similarity | NPD1038 | Approved |
0.664 | Remote Similarity | NPD4958 | Clinical (unspecified phase) |
0.6639 | Remote Similarity | NPD3795 | Approved |
0.6639 | Remote Similarity | NPD3258 | Approved |
0.6639 | Remote Similarity | NPD3794 | Approved |
0.6638 | Remote Similarity | NPD6975 | Discontinued |
0.6638 | Remote Similarity | NPD2739 | Clinical (unspecified phase) |
0.6638 | Remote Similarity | NPD5863 | Clinical (unspecified phase) |
0.6628 | Remote Similarity | NPD5532 | Phase 2 |
0.6627 | Remote Similarity | NPD7807 | Clinical (unspecified phase) |
0.6626 | Remote Similarity | NPD6824 | Clinical (unspecified phase) |
0.6626 | Remote Similarity | NPD1856 | Discontinued |
0.6624 | Remote Similarity | NPD6567 | Clinical (unspecified phase) |
0.6623 | Remote Similarity | NPD1739 | Approved |
0.6623 | Remote Similarity | NPD1740 | Approved |
0.6622 | Remote Similarity | NPD7291 | Discontinued |
0.662 | Remote Similarity | NPD2781 | Approved |
0.6614 | Remote Similarity | NPD4349 | Approved |
0.6614 | Remote Similarity | NPD4350 | Approved |
0.6612 | Remote Similarity | NPD7676 | Clinical (unspecified phase) |
0.6612 | Remote Similarity | NPD7674 | Phase 3 |
0.6612 | Remote Similarity | NPD7675 | Phase 3 |
0.6611 | Remote Similarity | NPD5417 | Clinical (unspecified phase) |
0.66 | Remote Similarity | NPD7853 | Phase 2 |
0.6599 | Remote Similarity | NPD5479 | Discontinued |
0.6598 | Remote Similarity | NPD6198 | Phase 1 |
0.6598 | Remote Similarity | NPD7547 | Clinical (unspecified phase) |
0.6594 | Remote Similarity | NPD3478 | Clinical (unspecified phase) |
0.6594 | Remote Similarity | NPD3477 | Phase 2 |
0.6588 | Remote Similarity | NPD8468 | Phase 2 |
0.6586 | Remote Similarity | NPD7922 | Phase 1 |
0.6585 | Remote Similarity | NPD4328 | Approved |
0.6585 | Remote Similarity | NPD4845 | Discontinued |
0.6584 | Remote Similarity | NPD5147 | Discontinued |
PubChem CID   | 284998 |
ChEMBL   | CHEMBL456295 |
ZINC   |
Molecular Weight:   | 381.12 |
ALogP:   | -0.5228 |
MLogP:   | 3 |
XLogP:   | 1.383 |
# Rotatable Bonds:   | 10 |
Polar Surface Area:   | 76.11 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 0 |
# Rings:   | 4 |
# Heavy Atoms:   | 28 |